HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 531262Generated: October 31, 2026
Potassium Carbonate → HCID 90009309, compound
https://huagongshe.com/reaction/531262
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Potassium Acetate | HCID 517044 | — |
| Reactant | Bis(pinacolato)diborane | HCID 2733548 | — |
| Reactant | Methyl 4-bromo-3,5-dimethylbenzoate | HCID 24820334 | — |
| Reactant | HCID 90009140 | HCID 90009140 | — |
| Catalyst | Palladium Chloride | HCID 24290 | — |
| Catalyst | HCID 178454861 | HCID 178454861 | — |
| Solvent | Dimethylacetamide | HCID 31374 | — |
| Product | HCID 90009309 | HCID 90009309 | 60.7% |
Reaction Steps
A mixture of (4S,5R)-3-{[5-(5-chloro-2-methoxypyridin-3-yl)-2-(methylsulfanyl)pyrimidin-4-yl]methyl}-5-[3-fluoro-5-(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one (INTERMEDIATE 18, 211 mg, 0.389 mmol), bis(pinacolato)diboron (296 mg, 1.17 mmol), and potassium acetate (114 mg, 1.17 mmol) in N,N-dimethylacetamide (2.0 mL) was degassed three times with nitrogen gas before the addition of (2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2-aminoethyl)phenyl)]palladium(II) chloride (XPHOS Biphenyl Precatalyst) (15.5 mg, 0.019 mmol). The system was degassed three times and was then heated to 130° C. for 24 hours. LC/MS analysis indicated complete conversion to the product, but almost exclusively as the boronic acid. For this reason the crude reaction mixture was taken directly into the next step. Accordingly, methyl 4-bromo-3,5-dimethylbenzoate (142 mg, 0.584 mmol), (1,1′-bis(di-tert-butylphosphino)ferrocene palladium dichloride (24.5 mg, 0.039 mmol), and aqueous potassium carbonate (0.389 mL, 2.0 M) were added. The mixture was degassed, flushed with nitrogen and heated to 100° C. for 45 minutes. The reaction was diluted with ethyl acetate, washed with water, brine, dried over sodium sulfate, filtered and concentrated. The crude product was purified by column chromatography to afford methyl 4-{5-[4-({(4S,5R)-5-[3-fluoro-5-(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-2-(methylsulfanyl)pyrimidin-5-yl]-6-methoxypyridin-3-yl}-3,5-dimethylbenzoate (158 mg, 0.236 mmol). LCMS (M+H)+: 671.1
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09353101B2 |
|---|
| Source dataset | uspto-grants-2016_05 |
|---|
| ORD ID | ord-be5e805b94de461ea6aec8ef7af213e8 |
|---|
| Source note | uspto-grants-2016_05 |
|---|